Compliance to multiple interventions in a high risk population

Annals of Epidemiology

Volumn 9, Issue 7, 1999, Pages 408-418

  Pettinger, Mary B ^a   Waclawiw, Myron A ^b   Davis, Kathryn B ^a   Thomason, Tracy E ^c   Garg, Rekha ^b   Griffin, Beate ^d   Egan, Debra A ^b  

^a Stat and Epidemiol Res Corp   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Clinical Trials; Patient Compliance; Peripheral Vascular Diseases

Indexed keywords

ANTIOXIDANT; NICOTINIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ANTIOXIDANTS; ASPIRIN; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NIACIN; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASES; PLACEBOS; PLATELET AGGREGATION INHIBITORS; PRAVASTATIN; TIME FACTORS; WARFARIN;

EID: 0032871563     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00010-1     Document Type: Article

References (21)

1. Bond W.S., Hussar D.A. Detection methods and strategies for improving medication compliance. AJHP. 48:1991;1978-1987.
2. Sclar D.A. Improving patient compliance. A Review of selected issues Clin Ther. 13:1991;436-440.
3. Coons S.J., Sheahan S.L., Martin S.S., Hendricks J., Robbins C.A., Johnson J.A. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 16(1):1994;110-117.
4. Regensteiner J.G., Steiner J.F., Panzer R.J., Hiatt W.R. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol. 2(3):1990;142-152.
5. Criqui M.H., Langer R.D., Franck A., Feigelson H.S., Klauber M.R., McGann T.J., Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 326:1992;381-386.
6. Nogues X., Senti M., Pedro-Botet J., Rubies-Prat J., Vidal-Barraquer F. Serum lipoprotein (a) levels in men with peripheral vascular disease [published erratum appears in Angiology 1991;42(12):956]. Angiology. 42(8):1991;659-664.
7. Senti M., Nogues X., Pedro-Botet J., Rubies-Prat J., Vidal-Barraquer F. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipid proteins and apoprotein E phenotypes. Circulation. 85(1):1992;30-36.
8. Steinberg D., Workshop Participants Antioxidants in the prevention of human atherosclerosis. Summary of the Proceedings of an NHLBI Workshop. Sept 5-6, 1991 Circulation. 85:1992;2338-2344.
9. Gaziano J.M., Manson J.E., Buring J., Hennekens C.H. Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci. 669:1992;249-258.
10. Nachman R.L. Blood thrombosis and atherogenesis. Molecular connections Blood. 79(8):1992;1897-1906.
11. Mattson M.E., Friedman L.M. Issues in medication adherence assessment in clinical trials of the national heart, lung, and blood institute. Controlled Clin Trials. 5:1984;488-496.
12. Stata Statistical Software. Release 4.0:1995;Stata Corporation, College Station, TX.
13. Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., Ouellette V.L. How often is medication taken as prescribed? JAMA. 261:1989;3273-3277.
14. Pullar T., Kumar S., Tindall H., Feely M. Time to stop counting the tablets? Clin Pharmacol Ther. 46:1989;163-168.
15. Rudd P., Byyny R.L., Zachary V., LoVerde M.E., Mitchell W.D., Titus C.et al. The natural history of medication compliance in a drug trial. Limitations of pill counts Clin Pharmacol Ther. 46:1989;169-176.
16. Rudd P., Byyny R.L., Zachary V., LoVerde M.E., Mitchell W.D., Titus C.et al. Pill count measures of compliance in a drug trial. Variability and suitability Am J Hypertens. 1:1988;309-312.
17. Jacobson T.A., Chin M.M., Fromell G.J., Jokubaitis L.A., Amorosa L.F. Fluvastatin with and without niacin for hypercholesterolemia. Am J Cardiol. 74:1994;149-154.
18. Andrade S.E., Walker A.M., Gottlieb L.K., Hollenberg N.K., Testa M.A., Saperia G.M.et al. Discontinuation of antihyperlipidemic drugs - do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med. 332:1995;1125-1131.
19. Schectman G., Hiatt J. Drug therapy for hypercholesterolemia in patients with cardiovascular disease. Factors limiting achievement of lipid goals Am J Med. 100:1996;197-204.
20. Radloff L.S. The CES-D Scale. A self-report depression scale for research in the general population Appl Psychol Measur. 1(3):1977;385-401.
21. Leng G.C., Fowkes F.G.R. The Edinburgh Claudication Questionnaire. An improved version of the WHO/Rose Questionnaire for use in epidemiologic surveys J Clin Epidemiol. 45(10):1992;1101-1109.